Pulmonary arterial hypertension
Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension.
... Interestingly, it is possible endothelial cell-derived microparticles may also vary among dif- ferent patient subsets, such as patients with compensated vs decompensated disease. It is cur- rently not known whether ...
18
Effect of thoracic epidural blockade on hypoxia-induced pulmonary arterial hypertension in rats
... Pulmonary arterial hypertension (PAH) is character- ized by profound increase in pulmonary vascular resistance in association with a degree of vascular proliferation and remodeling, ...
6
Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension
... pattern could be associated to BMPR2 mutations in 28 patients with iPAH and 27 patients diagnosed with PAH associated with other diseases found no difference in the methylation CpG islands of BMPR2 promoter region ...
12
Quality of life as a prognostic marker in pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) is a chronic dis- ease caused by elevated pressure in the lung vasculature, eventually leading to the right ventricle failure and death due to circulatory ...
6
The importance of echocardiography in diagnostics of idiopathic pulmonary arterial hypertension: A case report
... Case Outline A 47-year-old female presented with symptoms and signs of the right heart chambers failure. Over prior seven years the patient had the feeling of suffocation and fatigue when walking, and received treatment ...
4
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
... Plasma BNP is used for the diagnosis and staging of heart failure [29], because its levels become elevated in proportion to the degree of RV dysfunction and RV remodeling in PAH [30,31,32,33,34]. At 3 weeks, plasma BNP ...
12
Cor triatriatum sinister and secondary pulmonary arterial hypertension in a dog.
... with pulmonary edema and pulmonary hypertension in a 5-year-old Poodle female with history of acute dyspnea and ...of pulmonary artery tunica media associated with renal tubular ...
5
MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
... in pulmonary artery smooth muscle cells (hPASMCs) in pulmonary arterial hypertension ...the pulmonary artery (PA) from PAH and non-PAH patients (n = 3) was determined using ...
19
Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study
... We investigated whether chronic rosuvastatin administration could improve the abnormalities of the circulating levels of vascular dysfunction markers in pulmonary arterial hypertension (PAH). Sixty ...
7
Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI.
... The complex geometry and retrosternal location of the right ventricle (RV) confound accurate RV assessment by echocardiography. As a result, cine MRI is the reference standard for RV assessment due to its superior ...
14
Contrasting Cardiopulmonary Responses to Incremental Exercise in Patients with Schistosomiasis-Associated and Idiopathic Pulmonary Arterial Hypertension with Similar Resting Hemodynamic Impairment
... malities have been ascribed to the inability of the right ventricle to increase cardiac output through the pulmonary vascular bed, inefficient gas exchange due to ventilation-perfusion mismatching, and/or ...
6
Abnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasound.
... in arterial compliance (ie an increase in arterial stiffness) is of equal importance in ...in arterial stiffness that occur in PAH is fundamental to the understanding of progression to RV failure in ...
6
Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension.
... targeted pulmonary vasodilators in pediatric patients with PAH, 5- year estimated survival rate is still estimated at 74% ...higher pulmonary/systemic arterial pressure ratio, lower cardiac index, ...
7
Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension.
... Right heart catheterization (RHC) was performed in supine position from the right femoral vein access using a Swan-Ganz catheter in every patient. The acquisition of pressure waves was made at end expiration. Cardiac ...
11
Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.
... We previously described a large German family (S965) with 7 affected members in 3 generations [17]. This family had no identifiable mutations in BMPR2 gene by exonic sequencing or multiple ligation-dependent probe ...
10
Transudative Chylothorax in a Patient with Pulmonary Hypertension
... Our patient had no recent history trauma or invasive procedure, except thoracentesis and closed tube drainage ater hospital- ization. Biochemical evaluation of pleural efusion for the sec- ond thoracentesis revealed ...
3
Estudo de marcadores de disfunção endotelial e de inflamação em portadores de hipertensão...
... Microvascular dysfunction, involving endothelial cells, platelets and leukocytes, is present in pulmonary arterial hypertension (PAH), and is associated to higher risk t[r] ...
209
PDF EN Jornal Brasileiro de Pneumologia 5 15 english
... Pulmonary hypertension is a common complication of sickle cell ...in pulmonary artery pressures are slight, morbidity and mortality are ...patients, pulmonary hypertension is emerging ...
9
J. bras. pneumol. vol.33 número5 en v33n5a15
... Pulmonary hypertension is a common complication of sickle cell ...in pulmonary artery pressures are slight, morbidity and mortality are ...patients, pulmonary hypertension is emerging ...
9
Rev. Bras. Reumatol. vol.43 número5
... of pulmonary hypertension, and the development of unex- plained dyspnea or an isolated decrease in diffusing capacity should prompt ...untreated pulmonary hypertension occur- ring in the ...
8